[go: up one dir, main page]

DK1503803T3 - Injicerbar farmaceutisk sammensætning indeholdende ethanol til at behandle diskusprolaps - Google Patents

Injicerbar farmaceutisk sammensætning indeholdende ethanol til at behandle diskusprolaps

Info

Publication number
DK1503803T3
DK1503803T3 DK03752788T DK03752788T DK1503803T3 DK 1503803 T3 DK1503803 T3 DK 1503803T3 DK 03752788 T DK03752788 T DK 03752788T DK 03752788 T DK03752788 T DK 03752788T DK 1503803 T3 DK1503803 T3 DK 1503803T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
composition containing
injectable pharmaceutical
containing ethanol
disc prolapse
Prior art date
Application number
DK03752788T
Other languages
English (en)
Inventor
Jacques Theron
Original Assignee
Jacques Theron
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jacques Theron filed Critical Jacques Theron
Application granted granted Critical
Publication of DK1503803T3 publication Critical patent/DK1503803T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0409Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0085Brain, e.g. brain implants; Spinal cord
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Massaging Devices (AREA)
DK03752788T 2002-05-07 2003-05-07 Injicerbar farmaceutisk sammensætning indeholdende ethanol til at behandle diskusprolaps DK1503803T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0205819A FR2839450B1 (fr) 2002-05-07 2002-05-07 Preparation medicamenteuse notamment pour le traitement des hernies discales
PCT/FR2003/001412 WO2003097108A1 (fr) 2002-05-07 2003-05-07 Preparation medicamenteuse notamment pour le traitement des hernies discales

Publications (1)

Publication Number Publication Date
DK1503803T3 true DK1503803T3 (da) 2008-11-10

Family

ID=29286406

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03752788T DK1503803T3 (da) 2002-05-07 2003-05-07 Injicerbar farmaceutisk sammensætning indeholdende ethanol til at behandle diskusprolaps

Country Status (14)

Country Link
US (3) US20070116647A1 (da)
EP (1) EP1503803B1 (da)
CN (1) CN100402020C (da)
AT (1) ATE402719T1 (da)
AU (1) AU2003262617A1 (da)
CA (1) CA2498976C (da)
CY (1) CY1108413T1 (da)
DE (1) DE60322530D1 (da)
DK (1) DK1503803T3 (da)
ES (1) ES2309334T3 (da)
FR (1) FR2839450B1 (da)
PT (1) PT1503803E (da)
SI (1) SI1503803T1 (da)
WO (1) WO2003097108A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2839450B1 (fr) * 2002-05-07 2006-04-07 Aboville Marc D Preparation medicamenteuse notamment pour le traitement des hernies discales
FR2891461B1 (fr) * 2005-09-30 2010-09-03 Jacques Theron Preparation medicamenteuse visqueuse injectable comprenant de l'ethanol et un compose liposoluble opaque aux rayons x.
US12350341B2 (en) * 2017-03-02 2025-07-08 Duke University Methods for the treatment of cancer and benign lesions by ablation
CA3075219A1 (en) 2017-09-08 2019-03-14 Mina Therapeutics Limited Hnf4a sarna compositions and methods of use
WO2019048645A1 (en) 2017-09-08 2019-03-14 Mina Therapeutics Limited STABILIZED COMPOSITIONS OF SMALL ACTIVATOR RNA (PARNA) FROM CEBPA AND METHODS OF USE
US20220281911A1 (en) 2019-08-19 2022-09-08 Mina Therapeutics Limited Oligonucleotide conjugate compositions and methods of use
CN117222405A (zh) * 2021-03-04 2023-12-12 苏州医本生命科技有限公司 一种含乙醇的药物组合物及其用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2162028A (en) * 1938-06-25 1939-06-13 Pittsburgh Plate Glass Co Cellulose ether coating composition
US2903396A (en) * 1957-05-08 1959-09-08 Ciba Pharm Prod Inc Therapeutic compositions and method for treating parkinsonism
EP0304403A3 (de) * 1987-08-21 1990-12-12 Ciba-Geigy Ag Kunststoffzusammensetzung mit Supraleitern
JPH02157029A (ja) 1988-12-09 1990-06-15 Dainippon Pharmaceut Co Ltd アニオン系界面活性剤含有組成物の安定化
US5830178A (en) * 1996-10-11 1998-11-03 Micro Therapeutics, Inc. Methods for embolizing vascular sites with an emboilizing composition comprising dimethylsulfoxide
US6476070B2 (en) * 1997-09-11 2002-11-05 Provasis Therapeutics Inc. Compositions useful for remodeling body spaces
US6015541A (en) * 1997-11-03 2000-01-18 Micro Therapeutics, Inc. Radioactive embolizing compositions
US6150022A (en) * 1998-12-07 2000-11-21 Flex Products, Inc. Bright metal flake based pigments
AU5144600A (en) * 1999-05-21 2000-12-12 Micro Therapeutics, Inc. Methods for embolizing vascular sites with an embolizing composition
US6531111B1 (en) * 1999-05-21 2003-03-11 Micro Therapeutics, Inc. High viscosity embolizing compositions
US6355058B1 (en) * 1999-12-30 2002-03-12 Advanced Cardiovascular Systems, Inc. Stent with radiopaque coating consisting of particles in a binder
US20020115904A1 (en) * 2001-02-21 2002-08-22 Brooke Ren Magnetically controllable embolic materials
FR2839450B1 (fr) * 2002-05-07 2006-04-07 Aboville Marc D Preparation medicamenteuse notamment pour le traitement des hernies discales

Also Published As

Publication number Publication date
US20130143970A1 (en) 2013-06-06
US20070116647A1 (en) 2007-05-24
ES2309334T3 (es) 2008-12-16
ATE402719T1 (de) 2008-08-15
FR2839450B1 (fr) 2006-04-07
FR2839450A1 (fr) 2003-11-14
WO2003097108A1 (fr) 2003-11-27
DE60322530D1 (de) 2008-09-11
CY1108413T1 (el) 2014-02-12
SI1503803T1 (sl) 2008-12-31
EP1503803A1 (fr) 2005-02-09
AU2003262617A1 (en) 2003-12-02
US8153696B2 (en) 2012-04-10
US20100329991A1 (en) 2010-12-30
PT1503803E (pt) 2008-10-16
CA2498976A1 (fr) 2003-11-27
CN100402020C (zh) 2008-07-16
CN1665546A (zh) 2005-09-07
HK1081849A1 (zh) 2006-05-26
CA2498976C (fr) 2011-09-06
EP1503803B1 (fr) 2008-07-30

Similar Documents

Publication Publication Date Title
IL154888A0 (en) Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
DK1797053T3 (da) Phenothiazinium-forbindelse til sårheling
HRP20120004T1 (en) Dipeptidyl peptidase inhibitors for treating diabetes
WO2002011764A3 (en) PHARMACEUTICAL COMPOSITIONS
GT200800107A (es) Formulaciones orales que comprenden tigeciclina
DE60336225D1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
ATE367152T1 (de) Herstellungsverfahren für niedrig dosierte pharmazeutische zusammensetzung
CY1108413T1 (el) Ενεσιμη φαρμακευτικη συνθεση που περιλαμβανει αιθανολη για την αγωγη των δισκοπαθειων
BR0307518A (pt) Composição farmacêutica
UY28148A1 (es) Bromhidrato de escitalopram y un metodo para su preparacion
ITMI20041245A1 (it) Composizioni farmaceutiche iniettabnili comprendenti diclofenac sodico e b-ciclodestrina
WO2005058824A3 (en) N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprote in b
WO2004012722A3 (en) Bicifadine formulation
ECSP066860A (es) Formulaciones de matriz oral que comprenden licarbazepina
EA200501565A1 (ru) Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса
AR048672A1 (es) Tabletas de desintegracion que comprenden licarbazepina
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
SE0203817D0 (sv) New composition
NL1023797A1 (nl) Farmaceutische doseringsvorm die zwangerschapsvriendelijke onderscheidingstekens draagt.
ATE357220T1 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung
EP1556022A4 (en) Aqueous 2,6-diisopropylprophenol-containing pharmaceutical compositions
BR0110669A (pt) Composição oral.
ITTO20001109A0 (it) Composizione farmaceutica per il trattamento anti m. ulcerans.
ITMI20032417A1 (it) Composizione farmaceutica particolarmente per uso dermatologico.
ITTO20020352A0 (it) ,,composizione farmaceutica anti-depressiva contenente estratto di polygala,,.